Want to join the conversation?
$NWL's normalized EPS was $0.62, $0.01 ahead of consensus and 6.9% ahead of prior year despite having to overcome a $0.14 negative impact from foreign currency. 3Q15 core sales growth was broad-based with growth in all five segments and all four regions.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.